Functional Recovery Effect of Bloodletting Puncture at Jing-well Points on Acute Brain Injury Patients
NCT ID: NCT04930146
Last Updated: 2021-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2021-06-08
2024-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Acupuncture in Patients With Acute Intracranial Hemorrhage
NCT06243237
Adjuvant Acupuncture for Severe Head Injury
NCT01773291
Clinical Evaluation of Acupuncture on the Complications of Cerebral Vascular Accident
NCT02197663
Acupressure on Cognitive Function and Quality of Life
NCT04441645
Can Acupuncture Benefit Surgical Patients With Haemorrhagic Stroke?
NCT01037894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group (Severe)
A patient's Glasgow Coma Score (GCS) between 5-8
1. Conventional treatment and bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.
2. Evaluating the meridian energy by M.E.A.D
acupuncture and bloodletting
bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.
Control group (Severe)
A patient's Glasgow Coma Score (GCS) between 5-8
1. Conventional treatment.
2. Evaluating the meridian energy by M.E.A.D
No interventions assigned to this group
Intervention group (Moderate)
A patient's Glasgow Coma Score (GCS) between 9-13
1. Conventional treatment and bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.
2. Evaluating the meridian energy by M.E.A.D
acupuncture and bloodletting
bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.
Control group (moderate)
A patient's Glasgow Coma Score (GCS) between 9-13
1. Conventional treatment.
2. Evaluating the meridian energy by M.E.A.D
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture and bloodletting
bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient with normal consciousness and no cognitive or motor function disease before brain injury.
3. Patient aged between 20 to 80 years old and is willing to sign the consent (the agent can sign on behalf of patient).
Exclusion Criteria
2. Patients combined with other terminal illness such as cancer in terminal stage, liver failure, end stage renal failure and so on.
3. Pregnant patients.
4. Any other conditions deemed unsuitable by the physician in charge.
5. Patients (agent of the patient) who did not sign the consent.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
wei Ling Chou
Role: PRINCIPAL_INVESTIGATOR
Chang Gung Medical Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chang Gung Memorial Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Wei Ling Chou
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202100683A3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.